Rise of circulating thrombopoietin following cardiothoracic surgery is potentiated in patients with coronary atherosclerosis: correlation with a preceding increase in levels of interleukin-6.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsCotton, James M.
Humphries, Steve E.
Brown, Angie S.
Martin, John F.
Erusalimsky, Jorge D.
MetadataShow full item record
AbstractThrombopoietin (TPO) is the major regulator of platelet production. Plasma levels of TPO are thought to be regulated by its binding to platelets and megakaryocytes. Here we have used a model of cardiac surgery with cardiopulmonary bypass (CBP) to test the possibility that changes in TPO levels are influenced by the presence of coronary artery disease (CAD) and by changes in interleukin-6 (IL-6). After surgery patients with CAD (n = 22) or with normal coronary arteries (n = 11) showed a significant thrombocytopaenia followed by a reactive thrombocytosis. The platelet recovery was preceded by a significant rise in TPO (from 62.6 +/- 9.4 pg/ml at baseline to 129.2 +/- 19 pg/ml at 60 h, P <0.001), which in turn was preceded by, and was positively correlated with, a marked increase in circulating IL-6 (from 1.5 +/- 0.3 pg/ml at baseline to 269.3 +/- 30.6 pg/ml at 3-12 h, P <0.001). The rise of both IL-6 and TPO was significantly larger in patients with CAD. No correlation was found between the post-operative drop in platelet mass and changes in either the TPO or IL-6 levels. These findings suggest that in man circulating TPO levels, besides being controlled by changes in platelet mass, are influenced by inflammatory processes, including the presence of coronary atherosclerosis.
CitationThrombosis and Haemostasis, 89(3): 538-543
JournalThrombosis and Haemostasis
- The role of thrombopoietin in post-operative thrombocytosis.
- Authors: Folman CC, Ooms M, Kuenen B B, de Jong SM, Vet RJ, de Haas M, von dem Borne AE
- Issue date: 2001 Jul
- Differential mechanisms in the regulation of endogenous levels of thrombopoietin and interleukin-11 during thrombocytopenia: insight into the regulation of platelet production.
- Authors: Chang M, Suen Y, Meng G, Buzby JS, Bussel J, Shen V, van de Ven C, Cairo MS
- Issue date: 1996 Nov 1
- Circulating thrombopoietin in reactive conditions behaves like an acute phase reactant.
- Authors: Cerutti A, Custodi P, Mduranti, Cazzola M, Balduini CL
- Issue date: 1999 Aug
- Acute rise of circulating vascular endothelial growth factor-A in patients with coronary artery disease following cardiothoracic surgery.
- Authors: Cotton JM, Mathur A, Hong Y, Brown AS, Martin JF, Erusalimsky JD
- Issue date: 2002 Jun
- Thrombopoietin serum concentration in patients with reactive and myeloproliferative thrombocytosis.
- Authors: Uppenkamp M, Makarova E, Petrasch S, Brittinger G
- Issue date: 1998 Nov